Medica Special Autumn 2011

W A L E S m e d i c a s p e c i a l

Walesopen for business

W A L E S M E D I C A S P E C I A L 2 0 1 1

M E D I W A L E S I S S U P P O R T E D B Y T H E W E L S H G O V E R N M E N T


T: +44 (0)1792 797910F: +44 (0)1792 797955 E: [email protected]

COME AND VISIT US AT MEDICA STAND 16 F30

Our combination of high

quality innovative products

and exceptional levels of

service provide supreme

clinical value.

Your sterile single-use solution, without compromise

Specialities served: General and Vascular, ENT/MaxFax, Gynaecological, Neurosurgical

[email protected]

AT MEDICA STAND 16 F30

Vascular, rosurgical

eneral and VVascular

Forum Manager: [email protected] Manager: [email protected] Manager: [email protected] Coordinator: [email protected]: www.mediwales.comTelephone: +44 (0)29 2047 34567 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ

MediWales Chairman: Mr Greg Baily, Huntleigh

The MediWales Medica Special is designed by Teamworks Design and Marketing

Contents

Features

Wales: Open for Business 4-5Life Sciences - at the heart of Welsh Government 6-7

Wales Pavilion Directory 9-15

Company Case StudiesAlere Connected Health 16CellPath 17Chromogenex 18Direct Healthcare Services 19DTR Medical 20GX Group 21Pulse Medical Technologies 22

This MediWales “Medica Special” Review is your introduction to the thriving medical technology sector in Wales. It includes editorial from both MediWales and the Welsh Government, with a directory of all companies on the Welsh Government mission 2011. Several companies are represented further through case studies, providing a snapshot of some of the most exciting products and services being offered by Welsh companies in this sector.

Medica is the world’s largest and leading global exhibition for the medical sector, and has been established for over 40 years. It runs alongside the leading international fair for medical manufacturing supplies, Compamed. Together, Medica and Compamed occupy all 19 halls of the Düsseldorf Exhibition Centre and organisers expect more than 600 exhibitors from over 60 countries.

Medica covers the entire range of out-patient and in-patient healthcare, including: electrical medicine, medical devices, laboratory technology, diagnostics, physiotherapy, orthopaedic technology, medical supplies, (essential supplies and consumables)information and communication technology, textiles, medical furniture, furnishings, facility management, and building services.

At the same time, Compamed addresses all aspects of supplies to the medical manufacturing sector: raw materials, components, parts, packaging, and services for use in medical device production.

Medica 16 - 19 November 2011 – Messe Düsseldorf, Germany

The Welsh Pavilion: Hall 16 Stand F30

MediWales is a founder member of Medilink UK, a national

health technology business support organisation that represents

the interests of around 3000 organisations across the UK.

The Welsh Government is a democratically elected body, which was established in May 1999. It has devolved powers and is responsible for developing and implementing policies in Wales on a broad range of economic issues, including economic development, education, the environment, agriculture, housing, roads and transport.

This year’s Welsh delegates are supported by the Welsh Government to attend Medica. In spite of the economic situation, both MediWales and Welsh Government are confident this mission will benefit the delegates, ensuring networking opportunities to place Welsh life science companies firmly in the global spotlight once again.

MediWales has been active for over 19 years and is the representative body for the life science sector in Wales. Supported by the Welsh Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales. MediWales generates a unique environment for networking, collaboration and communications between industry, academia and health service members. This is delivered through an active schedule of events and publications supported by the MediWales website and maintained via constant communication with stakeholders. From this pivotal role, MediWales is able to represent both its members and the wider sector to governmental and international partners.

T: +44 (0)1792 797910F: +44 (0)1792 797955 E: [email protected]

COME AND VISIT US AT MEDICA STAND 16 F30

Our combination of high

quality innovative products

and exceptional levels of

service provide supreme

clinical value.

Your sterile single-use solution, without compromise

Specialities served: General and Vascular, ENT/MaxFax, Gynaecological, Neurosurgical

[email protected]

AT MEDICA STAND 16 F30

Vascular, rosurgical

eneral and VVascular

W A L E S m e d i c a s p e c i a l4

A devolved nation of approximately three million people, with an independent NHS and a thriving life science industry, Wales is aware of the opportunities being small offers.

Frequently facilitated by MediWales, senior decision makers in academia, business and the NHS regularly meet to discuss how to better Welsh healthcare and the economy. The focus of discussions this year has progressed from realising better communications to realising tangible outputs.

The resounding message is that Wales is open for business: with sub sector strengths in wound healing, diagnostics, assistive technology and clinical trials, this is the place to carry out your research and development (R&D). Since the Welsh Government restructured in summer 2010, 70% of all grants awarded have been to life science companies: companies understand that Wales not only offers a cost effective manufacturing base but houses the necessary skills, expertise and infrastructure to provide an excellent environment for research.

Feedback from Advamed – the largest American health technology trade association – on the perception of Europe as a destination for R&D holds potential consequences for Wales.

American companies’ experience infers that health technology trials and evaluations in Europe can be done

at half the time and cost, compared to in America. The design and patient recruitment for studies is viewed as simpler, with a free healthcare system naturally encouraging greater patient engagement.

This knowledge provides Wales with an opportunity to attract clinical trials/evaluations and commercialisation of medical technologies from outside Europe due to its unique size, networks and its devolved NHS.

The following section takes a brief look at just a few of the organisations that make Wales such an attractive location to carry out R&D:

Cardiff University: Welsh Anaesthetic Institute (WAI)

Working closely with medical devices manufacturers, the team of senior academics and consultant anaesthetists have an extensive portfolio including: developing patents; evaluating medical equipment using laboratory-based tests; user assessments and clinical trials; and expert consultancy. The international reputation and expertise of Dr Antony Wilkes, Research Director and CEN Consultant, cannot be underestimated.

They boast a state of the art Clinical Research Facility with excellent collaborative support from NHS Research and Development. Open for business, the institute welcomes contact from those wishing to initiate studies.

Penn Pharma

Penn is a leading provider of integrated pharmaceutical development, clinical trial supply and custom manufacturing services to the international healthcare industry. Offering specialised contract manufacture and Qualified Person release services, Penn are an excellent contract research organisation supplier. Penn manufactures to GMP (Good Manufacturing Practice) and is licensed by the UK’s MHRA (Medicines and Healthcare products Regulatory Agency) and is FDA (US Food and Drug Administration) inspected.

Cedar

Cedar is an NHS evaluation centre, providing information and recommendations on emerging health technologies, medical devices, diagnostic testing, healthcare interventions and NHS service configuration.

Cedar has a successful history of evaluation for a succession of UK government funded NHS organisations. Cedar is part of the Cardiff and Vale University Health Board (UHB) and has recently won a major 3-year contract with the National Institute for Health and Clinical Excellence (NICE) working on their Evaluation Pathway for Medical Technologies.

In addition to their work for NICE, Cedar is able to undertake bespoke work for organisations. Recent examples include work for the Medicines and Healthcare Products Regulatory Agency (MHRA), Department of Obstetrics and Gynaecology at Cardiff and Vale UHB and the medical device industry.

Wales: open for businessMediWales – the Welsh life science forum - works closely with Welsh Government departments for business and health, the NHS, academics and industry to ensure operations and policy in the Welsh life science sector reflect joined up, multi-disciplinary thinking. By Jess Fisher, MediWales

5

SMTL

The Surgical Materials Testing Laboratory, part of the Welsh NHS, provides a range of testing and technical services to the NHS and the medical device industry worldwide, including:

• Physical and Biological testing of disposable medical devices to National and International standards

• Dressings testing and bandage testing

• Biological and microbiological testing

• Hosiery and glove testing

• Environmental monitoring of cleanrooms (to ISO 14644-1 and GMP)

• Surgical instrument evaluations (single use and reusable)

• Test method development, R&D and incident investigation

Cardiff University – Wound Healing Research Unit (WHRU)

WHRU has three core activities: specialist clinical services, research, and education and training.

Research includes conducting clinical trials; biological research (with a particular emphasis on microbiology and material science); physical measurement (the interface of medicine and engineering/electronics); and health services research (including health economics). The target markets include health professionals working with non-healing acute or chronic wounds and health care companies involved in specialist wound care.

HIRU

The Health Information Research Unit (HIRU) based at Swansea University established the Secure Anonymised Information Linkage (SAIL) project to link together the widest possible range of anonymised person-based data using the School of Medicine’s IBM supercomputer (Blue C).

Having successfully accomplished this, HIRU is expanding the databank, both in types of dataset and in geographical coverage, providing a valuable resource for health-related research and service development, whilst complying with the requirements of data protection legislation and confidentiality guidelines.

eHealth Industries Innovation (ehi2) Centre

ehi² provides businesses with opportunities to test, adapt, improve and evaluate ehealth products and services in a safe and reliable environment. It advises and assists companies and can facilitate access to clinicians, academic experts, NHS organisations, and national NHS IT and ICT programmes. It works with the NHS and other health systems to identify needs for new products and services.

Institute of Life Science

Phase 2 of the Institute of Life Science at Swansea University is a £30 million facility providing state-of-the-art clinical research facilities, and an imaging suite. This institute provides an environment to undertake world-class and internationally recognised research, proving an excellent location for high-growth companies in the sector.

These organisations, and others, are supported and represented

through several

working groups created to influence the Welsh Government’s policies and agendas for Welsh healthcare.

MediWales’s contribution is through our clinical access group that has evolved into the more broad Life Science Expert Advisory Group, bringing key representatives from academia, business and clinical settings (ABC) together, with invited guests from Government, to suggest improvements to the healthcare system.

The Welsh Government’s National Institute for Social Care and Health Research (NISCHR) Academic Health Science Collaboration (AHSC) Advisory Task and Finish Group is developing a framework proposal for interaction between the NISCHR AHSC and Industry. A key part of NISCHR’s strategic work programme is developing an R&D infrastructure to build capacity and support excellence across Wales. The group will develop recommendations for maximising the attractiveness of Wales for partnering opportunities with the private sector, including ways to increase access to clinical trials.

Missions such as Medica are vital to this sector, providing a platform to build Wales’s reputation as a desirable place to do business, innovate and carry out specialist research.


Comprising pharmaceutical, biotechnology and medical technology businesses, Wales houses one of the largest medical device clusters in the UK, with a focus on diagnostics, wound care, e-health and contract research.

This burgeoning Welsh sector has grown by over 19 per cent in the last three years, no doubt partly attributable to its highly skilled workforce.

Many Welsh companies are leading players in their specialist areas, such as: medical technology (Biomet UK, Huntleigh and Gyrus ACMI - an Olympus company); diagnostics (Siemens Healthcare Diagnostics and Ortho Clinical Diagnostics); wound healing (ConvaTec, Biomonde and Frontier Medical Group); and contract research organisations and their supply chain (Aptuit, Biotec Services International and Penn Pharma).

“What’s happening here in Wales is comparable to many biotech hubs around the world, with a concentration of expertise and R&D excellence”, said Dr Stephen Minger, Head of Research and Development for Cell Technologies at GE Healthcare, Cardiff, home to the company’s international centre for groundbreaking work in stem cell technologies.

Complementary to GE’s stem cell centre, Wales is home to BTG - the UK’s biggest biotechnology group. Wales has a strong representation of in-vitro diagnostic companies, including Albany Molecular Research Inc. (AMRI), Quay Pharma and Quotient Bioresearch.

Wales has historically provided an excellent location to do business, with

Life Science – at the heart of Welsh Government

global companies such as Siemens Healthcare Diagnostics Products Ltd; Ortho Clinical Diagnostics, Biomet and Biomonde, choosing to locate parts of their business here.

Innvovation and Academic Strengths

In Wales you’ll find specialist organisations with industry-leading facilities, and partners who are taking the science forward with innovative techniques.

Recent Innovations:

Microvisk – Devices which monitor clotting levels for patients on drugs such as Warfarin.

Haemair – Respiratory aids which mimic the performance of healthy lungs.

Calon Cardio – Implantable pumps for treatment of heart failure.

Hall Lock System – Device which prevents healthcare staff from mistakenly injecting drugs and other substances into the wrong part of the body.

Huntleigh Diagnostics – Device which detects the early on-set of lower limb arterial disease.

Invacare – Portable oxygen filling system.

MedaPhor – Ultrasound training simulator.

Cal2Cal – Informatics – system to monitor chronic disease and improve preventative care of the elderly.

A priority sector for Welsh Government, the life science industry is diverse, research-driven and globally focussed, with new Welsh subsectors continuing to develop.


Recent Funds Raised include:

CellNovo £30mMicrovisk £10.5mQ-Chip £8.5mDiurnal £1mAcuitas Medical £700k +Calon Cardio £500k

Committing to developing the necessary infrastructure for Wales to do business in this sector, the Welsh Government has invested in projects such as Phase 2 of the Institute of Life Science at Swansea University. This development showcases the partnership between the School of Medicine and the NHS in Wales. This £30 million facility provides additional state-of-the-art clinical research facilities, an imaging suite, also housing the innovative Centre for NanoHealth and the forward-looking Centre for Health Informatics, Research and Evaluation (CHIRAL). This institute creates a fit-for-purpose working environment necessary to undertake world-class and internationally recognised research, proving an excellent location for high-growth companies in the sector.

To help advise Welsh Government on the development and delivery of a live life science strategy for Wales, the Life Science Sector Panel was appointed earlier in 2011. Chaired by well-known biotech

Why Wales?In Wales we know what inward investors need, and the commercial pressures you face – we’ve been helping companies locate here for decades.

People and training - A skilled workforce is among a company’s most important asset. Fortunately in Wales we have two medical schools and our universities supply over 34,000 graduates each year. With a track record of academic-industrial collaboration, our graduates have the skills to join your company. Good quality companies and universities keep graduates in Wales – explaining why our staff retention is higher than the UK average into the potential labour market.

Property - Wales has an exceptional variety of business property – from serviced offices to international headquarters; starter industrial units to R&D incubators - and we even have property with runway access or dedicated airspace.

Access to funding - We encourage business growth by identifying sources of support and funding in areas such as skills development, academic collaboration and business expansion.

To find out more about life science business in Wales, join us at our Medica stand, Hall 16 Stand nr F30, or contact us:

tel: 03000 6033000 email: [email protected].

entrepreneur Professor Sir Chris Evans, the team comprises industry experts.

Medical technology is an important subsector and the Life Sciences Team and Panel are committed to support business growth in this area. This is clearly demonstrated in the support given to Welsh businesses to attend Medica this year, with 40 business exhibitors and delegates attending this medical technology trade fair, the largest in the world.

Supporting International Business SuccessThe Welsh Government’s Life Science Team focus on identifying and assisting companies to locate and increase their business in Wales. The team is exploring the business methodologies and supply chains of existing life science companies in Wales in order to create a strategy that will enhance and develop the cluster.

The team can offer advice and support for inward investment, accessing skills and employee development, access to NHS procurement advice, trade and export development, innovation, R&D, and commercialisation. Welsh Government offers financial support to eligible companies developing R&D and innovation in Wales and those significantly growing their business footprint.

From left to right, Dr Graham Guildford, Professor Sir Chris Evans, Dr Penny Owen, Professor Gareth Morgan, Gwyn Tudor

7


MATCH advert

How can MATCH help my business? The MATCH Affiliate Scheme will provide you with access to experts who will support your staff, helping

them transform your company's competitive performance by embedding flagship techniques, derived

from best-practice in healthcare technology assessment and user needs analysis.

Our research. Your business.The perfect MATCH

The Multidisciplinary Assessment of

Technology Centre for Healthcare

(MATCH) is a well-established research

collaboration between four leading

UK universities (Birmingham, Brunel,

Nottingham & Ulster) and is funded

since 2003 by the Engineering and

Physical Sciences Research Council

and partner contributions.

For further information please contact Elizabeth Deadman [email protected] 01895 266050 or check the MATCH website: www.match.ac.uk/sme.php

®

MATCH helps improve decision-making for technology

suppliers and procurement agencies. It enables

companies to identify better products earlier in the

design process and bring them to market sooner, with

greater confidence that the value to patients and others

will be consistently defined and readily recognised.

To this end, MATCH delivers: standardised methods for

establishing clinical value; new approaches to capturing

user needs for early design and in-use upgrades; best of

breed research into production and decision-making

processes; and a forum for engaging regulators and

finding better ways forward for all concerned.

What MATCH doesAssesses value …

…by developing methods and models to assess the value of

products at each stage of development, from identification of

need through to mature offerings in the market.

Optimises product development and manufacture…

…by researching processes for improving information and

decision-making, leading to more effective development and

production processes, better clinical integration and improved

provision for users.

Engages end users…

…by employing empirically based valuations of health and

related benefits to inform value models and develop methods for

engaging with users at the conception and design stages.

Focuses on Industry…

…by maintaining a strong industrial perspective, and using real

industrial problems to drive and ground its research activities.

About MATCH

MAT

CH

01

Asalus Medical Instruments Limited8th Floor Eastgate House35-43 Newport RoadCardiff, UK, CF24 0ABTel: +44 (0) 292 049 7097Website: www.asalus.co.uk

Alere Connected Health (ACH) formerly Home Telehealth Ltd (now part of the Alere group) is a telehealth and telemedicine organisation specialising in the provision of clinical managed services and telemedicine technologies for remote health and social care monitoring of patients with long-term conditions. ACH has won three consecutive National Awards in 2008-2010 for “Innovation and Partnering with the NHS”, with over 10 years’ experience in delivering telehealth, telemedicine and technology-enabled care to NHS and Local Authority health and care organisations.ACH has delivered services to the NHS to over 1,200 long term condition (LTC) patients reducing unplanned emergency admissions by 50%, with a return on investment (ROI) of 112%, thereby allowing patients to remain at home whilst providing support and education to facilitate better self-management. Objectives at Medica:Identify telemedicine and telehealth technologies that ACH can use on their programmes or distribute in the UK market and also look for European distributors of products they have access to.

The Welsh Government is a democratically elected body. It has devolved powers and is responsible for developing and implementing policies in Wales on a broad range of economic issues, including economic development, education, and technology and innovation. Life Science is a priority sector for the region, and a dedicated team is in place to support the growth of the life science sector in Wales

Asalus is developing three innovative medical devices for laparoscopic surgery. The company was founded by the prestigious training institute WIMAT, a leading UK training facility for minimal access surgery. Its lead product is Innervision which offers a paradigm shift in the way in which surgical smoke is handled. Based upon proven technology used in commercially available non-medical products, the Innervision system has the following benefits:l Effective – rapidly clears smoke without requiring intervention by

the surgeon l Silent, non-intrusive – does not require an air handling system or

impact current surgical techniques and instrumentation l Convenient – no de-sufflation of the abdominal cavity l Highly efficient – no additional carbon dioxide use required l Non-drying – does not require carbon dioxide exchangeIts follow-on products are a novel atraumatic manipulator and a variable length access port. Asalus intends to launch Innervision in 2012 and is seeking discussions with potential commercial and contract manufacturing partners.

Mob: +44 (0)7876 712021 Customer Care Team Tel: +44 (0) 161 483 5884 Fax: +44 (0) 161 483 5778 Email: [email protected]: muxwo123Web: www.hometelehealthltd.co.uk and www.alere.co.uk

Welsh GovernmentLife Science SectorTel: +44 (0)3000 6 03000Email: [email protected]

Alere

Welsh Government - Life Science Sector

Asalus

9

Attending: Cari-Anne Quinn, Senior Business Development Manager Chris Davies, Business Development Manager Tony Sagona, Business Development Manager

W A L E S P A V I L I O N D I R E C T O R Y

Attending: David Muxworthy, Director of Alere Connected Health Ltd (formerly Home Telehealth Ltd)

Attending: Dr Dominic Griffiths, Managing DirectorDr Peter Grant, Chairman

How can MATCH help my business? The MATCH Affiliate Scheme will provide you with access to experts who will support your staff, helping

them transform your company's competitive performance by embedding flagship techniques, derived

from best-practice in healthcare technology assessment and user needs analysis.

Our research. Your business.The perfect MATCH

The Multidisciplinary Assessment of

Technology Centre for Healthcare

(MATCH) is a well-established research

collaboration between four leading

UK universities (Birmingham, Brunel,

Nottingham & Ulster) and is funded

since 2003 by the Engineering and

Physical Sciences Research Council

and partner contributions.

For further information please contact Elizabeth Deadman [email protected] 01895 266050 or check the MATCH website: www.match.ac.uk/sme.php

®

MATCH helps improve decision-making for technology

suppliers and procurement agencies. It enables

companies to identify better products earlier in the

design process and bring them to market sooner, with

greater confidence that the value to patients and others

will be consistently defined and readily recognised.

To this end, MATCH delivers: standardised methods for

establishing clinical value; new approaches to capturing

user needs for early design and in-use upgrades; best of

breed research into production and decision-making

processes; and a forum for engaging regulators and

finding better ways forward for all concerned.

What MATCH doesAssesses value …

…by developing methods and models to assess the value of

products at each stage of development, from identification of

need through to mature offerings in the market.

Optimises product development and manufacture…

…by researching processes for improving information and

decision-making, leading to more effective development and

production processes, better clinical integration and improved

provision for users.

Engages end users…

…by employing empirically based valuations of health and

related benefits to inform value models and develop methods for

engaging with users at the conception and design stages.

Focuses on Industry…

…by maintaining a strong industrial perspective, and using real

industrial problems to drive and ground its research activities.

About MATCH

MAT

CH

01


Awen Consulting is a wholly owned subsidiary of the University of Wales (UW), providing project-managed services via a number of world class UW institutions and affiliates. The Consulting group specialises in developing medical devices from prototype to market and draws on a wide pool of academic expertise including: UW Global Academy and Faculty, the Alliance, Swansea Metropolitan University and Trinity St. David. Awen also works closely with the Institute of Life Science and the College of Engineering at Swansea University. Expertise drawn upon includes medical and medical approvals processes, microbiology and genetics, engineering and physics, computer science, mathematics, product design and product approval. Awen provides business, management and marketing support through the business schools. For manufacturing, Awen engages with UK manufactures where possible including plastic assembly, electronics, pharmaceutical and drug delivery.Awen also has links to, and can initiate discussions with, Venture Capital and Health Care Funds.

Boots Centre for Innovation Institute of Life ScienceUniversity of SwanseaSwansea, Wales, UK SA2 8PPTel: +44 (0) 1792 513 722Email: [email protected]

The Boots Centre for Innovation seeks out innovative health and beauty products at any stage - from concept to shelf-ready - for Boots pharmacy-led stores worldwide. They are looking for consumer healthcare opportunities that can form part of the Boots Pharmaceuticals range as there are specific unmet innovation needs. In return Boots offers entrepreneurs an array of support services that can help with the commercialisation of ideas. Embracing the principles of open innovation, the Centre compliments the established product development resources of Alliance Boots. Objectives at Medica: l Seek out innovative consumer healthcare products and services

which are suitable for Boots stores in the UK and throughout the global Boots distribution network.

l Identify opportunities that could meet customers’ unmet healthcare needs.

80 Mochdre Enterprise ParkNewtownPowys SY16 4LE Tel: +44 (0)1686 611333Fax: +44 (0)1686 622946Web: www.cellpath.co.uk

CellPath has established itself as a dynamic innovative company, and has anenviable reputation over 40 years for reliability and customer service in its role as market leading supplier of cellular pathology consumables. In addition to supplying a comprehensive range of pathology consumables, CellPath continues to be at the fore-front of the design and development of new products and services.Objectives at Medica:Increase export market by meeting potential and existing suppliers, distributors and customers.

Boots Centre for Innovation

CellPath

Awen Cymru

Attending: Gail Eastaugh, Business Development Manager

Attending: Dr. Marcus Heuberger, MInstKT, Technology Transfer ManagerTel: +44 (0)7949906262 Tegid Roberts, Tel: +44 (0)7971907747, Email: [email protected]

Attending: Philip Webber, Managing DirectorMark Wilson, Export Sales Manager

10

Units 1 & 2 Heol Rhosyn, Dafen Industrial Estate LlanelliCarmarthenshire SA14 8QGTel: +44 (0)1554 755444Fax: +44 (0)1554 [email protected]

Chromogenex is the UK’s leading developer and manufacturer of laser and intense pulsed light systems for the health, cosmetic and beauty market. Chromogenex have an extensive range of key products including: iLipo Ultra for fat reduction and body contouring, with vacuum massage which enhances lymphatic drainage including infra red skin tighteningFusion3DLift – a non-invasive face lift 3D rejuvenationRegenlite – a pulse dye laser for vascular, acne and skin pigmentationChromogenex also sell peripheral consumables, service contracts and ancillary goodsPhaser 808 - a laser diode for hair removalThe company has established direct sales operations in the UK, USA, Spain and South African markets with further export sales via a comprehensive global network of distributors.Objectives at Medica:To showcase the company’s latest product innovations.

Chromogenex

Dermastar

Dermastar Ltd is a manufacturer of “home based” medical products based in the United Kingdom. They specialise in the development of innovative and cost effective solutions within the aesthetic and dermatological market. Their latest product, AcneStar® offers a breakthrough spot medication and treatment for acne. A revolutionary drug and chemical free acne treatment AcneStar® is a quality product of Dermastar Ltd that has gone through three years of design and product testing. The research and development of AcneStar® was partly funded by the Welsh Development Agency.Acnestar is certified as meeting the requirement of EC Directive 93/42/EEC on Medical Device Annex IV for acne treatment and International Recognition.

Dermastar Ltd23 Frogmore StreetAbergavennyMonmouthshire NP7 5AHTel: +44 (0)1873 851555Fax: +44 (0)1873 851566Email: [email protected]: www.acnestar.co.uk

Direct Healthcare Services LtdUnits 8-10 Withey Court Industrial Estate, Western Industrial Estate, Caerphilly, Wales, UK CF83 1BQ Tel: +44 (0) 7837 242 731 (Neil) +44 (0) 7989 935 101Tel Enquiry: +44(0)845 459 9831Fax: +44 (0) 845 459 9832 Email: [email protected]

Multi award winning Direct Healthcare Services Ltd aspire to be one of the market leaders in the manufacturing process, supply, installation and service of pressure area care equipment.With its primary manufacturing operation based in South Wales, Direct Healthcare’s management team have a wealth of experience in the provision of clinically proven, value for money solutions in this specialist sector.Their combination of innovative technologies, designed in partnership with leading clinical healthcare establishments, meets the needs of most patient groups, including the increasingly elderly population. Specialist teams are dedicated to serving customer needs, whilst continually striving to provide excellent customer support through a personalised one-on-one service.Whether you need the provision of a managed pressure care contract, hospital installation or purchase of a single item, Direct Healthcare Services can meet your requirements.

Direct Healthcare Services

11


Attending: Peter McGuinness, Managing DirectorKevin Williams, Sales Director and Director

Attending: Jon Lewis/Neil Smith (Directors)


GX Group compromises of GX Design Engineers – Wales’ leading independent product design consultancy, GX Systems – a leading automation, control, I.T solutions and web based tracking developer and GX Environmental – UK market leaders in the design, installation and support services for tankered clean water and waste management logging.GX Design Engineers offers clients within the medical industry a holistic approach to new product development and innovation. Their multidisciplinary design team is experienced in handling projects from conception through to production and implementation. Skills include industrial and mechanical design, electronic hardware and software design, ergonomics including user interfaces, optronics and mechatronics. Benefitsl Cost-effective approach to reduce risks and maximise your ROIl Confident and proven technical expertise l Successful products tailored to their marketObjectives at Medica:To establish and present the recently formed GX Group and its component companies to the forefront of the European medical industry – focusing on medical manufacturers and service providers.

GX Group

DTR Medical Ltd17 Clarion CourtEnterprise ParkSwansea SA6 8RFTel: +44 (0)1792 797910Fax: +44 (0)1792 797955Email: [email protected]: www.dtrmedical.com

DTR Medical provides medical professionals with single-use sterile surgical instruments that deliver patient and clinical value combined with exceptional levels of service. The company has operated for six years and currently has more than 400 UK & international customers. The DTR Medical range includes many new sterile single-use surgical instruments for specialities including ENT, neurosurgery, vascular and general surgery, and gynaecological procedures, with a new orthopaedic surgery selection being launched at Medica 2011. In addition, the company supplies a range of products for sterile services including sterile pre-cut silicone tubing. DTR Medical continually expands its product range to meet new market demands.Objectives at Medica:Recruit new international distributors to sell the new product range worldwide; meet existing distributors and suppliers; and look for new products.

EnviroPulp Ltd, Newbridge Road Industrial Estate, Pontllanfraith, Gwent, NP12 2AN, Wales Tel: +44 (0)1495 228838 Email: [email protected]; [email protected] Web: www.enviropulp.co.uk

Enviropulp is a leading producer of high specification pulp products for use in hospitals, clinics and care homes. Products exceed the requirements of all relevant international standards. Their approach is to manufacture and supply the very best quality pulp products available today. The company has recently opened its new high technology manufacturing facility, with the most advanced thermo-forming pulp production equipment in the world. EnviroPulp continue to develop innovative and unique products for use in the medical market. Objectives at Medica: Showing the new Soap-Proof Washbowl and new line of high tolerance ThermoPulp Medical Trays. They are looking to meet with potential professional distribution partners on a global basis who can see the potential of the products in their markets.

DTR Medical

EnviroPulp

12

Attending: Andrew Davidson, Managing Director, Caroline Denise Mee, Business Manager

Attending: Fuad Khan, Commercial/Technical Director; Harry Kirk, Managing Director

Attending: Claire Banks, Business Development Manager, [email protected] Wetherall, Industrial Designer, [email protected]

The Mayfield Usk, Monmouthshire NP15 1SY Tel: +44 (0)1291 673437Fax: +44 (0)1291 673438Mobile: 07790315250 Email: [email protected] Web: www.gxgroup.com

Tel: +44 (0)29 20485885Email: [email protected]: www.huntleigh-diagnostics.comHall 9; Stand A32

Huntleigh, a member of the Getinge group of companies, is a leading global provider of innovative and high quality medical equipment for healthcare professionals. The Diagnostic Products Division can proudly boast world leading brands such as Sonicaid, Dopplex and Smartsigns, covering healthcare requirements in obstetrics, vascular assessment and patient monitoring. The ISO 13485 accredited site at Cardiff is the largest manufacturer of foetal monitors in the UK and its position has been strengthened with the introduction of portable foetal monitors; monitors with telemedicine capabilities and electronic viewing; and archiving systems. The Smartsigns brand of patient monitors compliment the obstetric and vascular business enabling Huntleigh to offer complete solutions to medical professionals world-wide. The site also offers expertise in electronic components and software that support product lines throughout the entire group.

Huntleigh

Magstim maintains a strong commitment to R&D and product improvement. Collaborating with researchers in British and European major centres of expertise (as well as those in North America and Japan) ensures that Magstim remains informed about clinical and medical advances, enabling the company to develop products at the forefront of technology.Products are sold directly to hospitals and clinics in the UK and Ireland and exports account for much of the Magstim business. Principal markets are in Germany, France, Benelux, Japan, the Far East and the USA. Magstim enjoys a close and effective relationship with its specialist distributors and provides significant training and after sales service.

The Magstim Company LtdSpring GardensWhitlandCarmarthenshire SA34 0HRTel: +44 (0)1994 240798Fax: +44 (0)1994 240061Email: [email protected]: www.magstim.com

Magstim

MediWales has been active for over nineteen years and is the representative body for the life sciences sector in Wales. MediWales is in regular communication with over 1700 named contacts, and currently has over 130 subscribed members.Supported by the Welsh Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales.MediWales generates a unique environment for networking, collaboration and communication between industry, higher education and health service members. This is delivered through an active schedule of seminar events and publications, supported by the MediWales website and maintained via constant communication with members and stakeholders. From this pivotal role, MediWales is able to represent both its members and the wider sector to governmental and international partners.Objectives at Medica:To support and promote members’ activity and to engage with the wider life science sector from Wales, the UK and beyond.

7 Schooner WayAtlantic WharfCardiff CF10 4DZTel: +44 (0)29 2047 3456Email: [email protected]: www.mediwales.com

MediWales

13


Attending: John Scandone, Director of Sales & MarketingSam Jacobs, Customer Support Engineer

Attending: Debbie Laubach, Project Manager

Attending: Greg Baily, Technical Director


PDR is a world renowned design and innovation consultancy and research centre.Over the last 17 years they have been using their unique and highly accessible approach to help large and small companies from around the world to discover, design and develop many successful medical devices and services encompassing classifications from simple disability devices and medial furniture through to complex diagnostic tools and drug delivery systems. Device development at PDR is undertaken through a proven design methodology that employs the latest design and manufacturing analysis tools and technologies to produce robust, compliant and commercially successful solutions.

PDR (The National Centre for Product Design and Development Research)Western AvenueCardiff, Wales CF5 2YBwww.pdronline.co.uk

Pelican Feminine Healthcare LtdCardiff Business ParkCardiff, Wales, CF14 5WFTel: +44 (0)2920 747000Fax: +44 (0)2920 747001Web: www.pelicanfh.co.uk

Pelican manufactures a range of single-use instruments, specialising in Gynaecology products, which include the market leading PELIspec.With state of the art manufacturing facilities and active research and development, the company has been instrumental in bringing many innovative products to the healthcare market. This, together with a positive input from specialist clinicians and other professional customers, ensures that Pelican remains at the forefront of providing clinically and cost effective products. Pelican is passionate about delivering high quality medical products and world class levels of customer service. Their commitment to the Feminine Healthcare Market has led to the recent acquisition of Clinical Innovations Europe, who specialise in obstetrics and gynaecology instruments.Objectives at Medica: They are looking to meet new European distributors (particularly from Romania, Hungary and Bulgaria) for their products as well as to meet inventors, suppliers or manufacturers of innovative obstetric and gynaecological products.

PDR

Pelican Feminine Healthcare

Polymer Health Technology

Polymer Health Technology LtdFestival DriveEbbw Vale, Wales NP23 8XETel: +44 (0)1495 30228Mob: +44 (0)7810 821382 (David)Mob: +44 (0)7966 841551 (Nick)Fax: +44 (0)1495 350189Web: www.polyhealth.com

Polymer Health Technology is Europe’s leading independent manufacturer of medical grade hydrophilic foam. Supplying exclusively to the medical industry and working to ISO 13485, Polymer Health Technology works in confidence with its partners to produce bespoke solutions to customer requirements. Hydrophilic foam is manufactured in a range of thicknesses and presented in bulk roll format or slit to customer desired widths. Foam can also be laminated to PU film or foam substrates. Formulations can be customised to incorporate antimicrobial or other beneficial additives to customer specific needs.Having grown rapidly through 2011, Polymer Health Technology is currently expanding its manufacturing capabilities. With additional production facilities coming on stream in 2012, they will be furthering their ability to provide a high quality of service to customers and continue to develop innovative products.

14

Attending: Jarred Evans, Commercial Director Tel: +44 (0) 2920 41 6725 Email: [email protected] Ashley Bryant, Senior Designer Tel: +44 (0) 2920 41 6725 Email: [email protected]

Attending: David Squirrell, Nick Woodman

Attending: James Eagle, Export Sales ManagerSimone Steventon, Business Development Manager

Welsh Wound Network

Pulse Medical Technologies

Tonus Europe

Tonus Europe LimitedTredegar Business ParkTredegarBlaenau Gwent NP22 3EL, UKTel: +44(0)79 888 111 75Email: [email protected]: www.tonuseurope.com

Tonus Europe Limited is creating new business opportunities in Western Europe, and wishes to distribute its products into new markets globally. Its UK office is part of the Tonus Healthcare Group whose headquarters is in the Latvian city of Liepaja on the Baltic coast.Formed in 1995 with its new offices in the UK, Tonus are seeking distributors and partners for its existing and future product range. Tonus manufactures a wide variety of elastic medical products, ranging from elastic bandages to complex corsetry. Tonus has established a market leading range of textile support, compression stockings and bandaging products sold through a well established sales channel in Eastern Europe.Collaborating with universities and manufacturers here in the UK, Managing Director Chris Groves expects that his new base in Wales will lead to opportunities for new business, research and development projects as well as commercial ties between UK, the Baltics and beyond.

Pulse Medical Technologies LtdInstitute of Life Science Swansea University Singleton Park Swansea SA2 8PP Mob: +44 (0)792 1227776 Tel: +44(0)1792 606670Email: [email protected]: www.pulsemedtech.com

Pulse Medical Technologies Ltd was incorporated to design and develop healthcare products, initially for the pain relief market. The company has expanded its operations into other areas of healthcare, including wound care, using its core technology of Pulsed Electromagnetic Field Therapy (PEMF) as the base.The company was awarded a major FP7 EC grant after submitting an idea for a new wound treatment, which incorporates the known healing properties of PEMF and the anti-bacterial properties of silver, within a unique dressing. A consortium was assembled to undertake the project and includes Swansea University and BSN Medical. Pulse’s R&D base resides in the Institute of Life Sciences within Swansea University, giving it direct access to the extensive research facilities and world class experts in the medical and engineering fields, enabling the instigation of further research projects and expansion of the PainWave pain relief product portfolio.

15


Attending: Chris Groves, Managing Director Dana Preiss, Sales Director Gatis Sturis, Export Specialist

Attending: Iain Elder

Wound Healing Research Unit (WHRU)School of MedicineCardiff UniversityHeath ParkCardiff CF14 4XNTel: +44 (0)29 2045 3945Email: [email protected]

The Welsh Wound Network is a new collaborative organisation dedicated to improving the clinical care of people with wounds in Wales. The network brings together the wealth of academic, clinical and commercial expertise in wound healing in Wales to facilitate the development of new practices and innovations by undertaking high quality collaborative research, audit and other enquiries.There are several well known and internationally respected research and clinical groups located in Wales including the Wound Healing Research Unit, the Surgical Materials Testing Laboratory, the All-Wales Tissue Viability Nurse Forum among several others. In this new venture all of these well established groups have come together to explore areas where collaboration would lead to enhancements in research, practice and commercial innovation. This ongoing communication is supported by a roster of conferences and other networking events throughout the year.


Alere Connected Health Ltd (formerly Home Telehealth Ltd) has over 12 years’ experience in delivering telehealth, telemedicine and technology-enabled care to the NHS and public and private healthcare organisations.

The company has delivered a full clinical managed service model for patients with long term conditions (LTC) over a four year period incorporating over 1,200 patients and 1,500 episodes of care. The telehealth managed service is a revenue not a capital model of care, enabling NHS Trusts and private healthcare providers to budget carefully and realise savings immediately. Old capital models of LTC management incorporating

Due to Alere’s ‘first to market’ position in the UK in delivering such a service, Alere Connected Health Limited has won three consecutive National Awards in 2008-2011 for “Innovation and Partnering with the NHS”.

Alere Connected Health

Alere Connected Health Ltd Saint Line House Mount Stuart SquareCardiff CF10 5LR Tel: +44 (0)7876 712021 Email: [email protected]: www.hometelehealthltd.co.uk www.alere.co.uk

16

expensive “front loaded” expenditure on technology are now consigned to history.

The chronic disease managed service incorporates all elements of a service delivery model including clinical and technical triage, installation, de-installation, maintenance and support services, appropriate technology identification for the patient’s particular LTC, and purchase of all equipment together with customised data collation and feedback to the customer.

This final element is critical in supporting such a service model as it provides evidence to the commissioners of the benefits and outcomes achieved, whether that is a quick return on investment (ROI), reductions in unplanned emergency

admissions, the ability to discharge patients quicker from secondary care, or improvements in patients’ quality of care. Real data headline outcomes include 112% ROI, 50% reduction in unplanned emergency admissions across a number of high admission disease conditions, support to community clinicians in prioritising growing caseloads, and improvements in quality of care for patients.

CellPath Ltd manufactures a wide range of products for the cellular pathology laboratory, also providing a unique archiving solution for pathological material. With a large in-house plastic injection moulding facility, bulk chemical mixing and packaging and distribution operation, they provide a world-wide service, backed up by numerous dealers and resellers.

Their primary aim is to provide a first class service by delivering high quality histology and cytology consumables. This is achieved by continuous process improvement, internal audits and monitoring of all comments, suggestions and any complaints received from internal and external customers.

Currently accredited to ISO 9001:2008, CellPath plan to achieve ISO 13485:2003 accreditation by the end of 2011 and ISO 14001:2004 in 2012.

Many products offer cost-effective solutions to laboratories, with a comprehensive range of processing cassettes, slides, histological wax, filled specimen pots and stains and dyes, along with other laboratory consumables.

At Medica, CellPath will showcase a new innovative range of cassettes introduced to solve the problem of tracking large tissue specimens through the laboratory. In addition, Medica gives the company an opportunity to show how a Welsh

CellPath Ltd80 Mochdre Enterprise ParkNewtown Powys SY16 4LETel: +44 (0) 1686 611 333Email: [email protected]: www.cellpath.co.uk

CellPath

manufacturer has global ability in a growing market.

Their CellNass storage solution is proven, established and cost effective for the retention of pathological material in conditions required by local controlling bodies. The service was designed by experienced laboratory and business people for the specific needs of cellular pathology.

17


i-Lipo™ is the latest in laser lipolysis, offering a way to achieve inch loss and body contouring with no pain, no needles and no down time. i-Lipo™ is clinically proven, safe and painless targeted fat reduction, with immediate results, manufactured and maintained in the UK.

The new i-Lipo Ultra Plus incorporates 36 laser diodes, vacuum massage with infra-red skin tightening to target more stubborn fatty deposits, enhance lymphatic drainage, improve blood circulation and promote skin renewal. i-Lipo Ultra Plus can deliver immediate results: the vacuum massage action of the Ultra enhances the removal of released fat cell contents. Its suction action optimises absorption of infra-red laser in the dermis to promote collagen growth and enhance blood circulation in the area. The result is slimmer, tighter and smoother looking skin.

Chromogenex have recently received a clinical evaluation from Paris for i-Lipo. The study was a prospective evaluation of 15 patients (12 women, 3 men) during a course of 8 i-Lipo treatment sessions over 4 weeks.

The included subjects were chosen as having a history of ‘resistant’ anatomical areas that had previously demonstrated nil improvement to regular gym exercise and diet control alone. 7 subjects had treatments on the thigh and 8 subjects had abdominal treatments. Direct circumference measurements of treated anatomy and echography measurements of fat layer thickness were recorded.

The second part of the study, histological and biological analysis was

Chromogenex

performed on human skin explants maintained in survival conditions, using light microscopy and assaying glycerol collagen synthesis levels after 5 i-Lipo simulated treatments on the tissue versus control (untreated) tissue.

Circumference measurements: An average of 4.16cms was reduced from (8) abdominal treatments.

An average of 1.5cms was lost from (8) thigh treatments

Please contact Chromogenex directly for more information on the results of this study.

Chromogenex LtdUnits 1 & 2 Heol Rhosyn Dafen Industrial Estate LlanelliCarmarthenshire SA14 8QGTel: +44 (0)1554 755444Fax: +44 (0)1554 [email protected]

18

Before

After

Direct Healthcare Services Ltd (DHS) was created less than three years ago in the medieval castle town of Caerphilly, South Wales.

Spearheaded by Managing Director Jon Lewis, DHS possesses a wealth of experience in the manufacturing processes and provision of clinically proven, pressure care solutions. The company has enjoyed tremendous growth since conception, winning three national awards in two years.

Having achieved 20% growth year on year within its primary UK market, DHS is looking to maximize export market opportunities.

Direct Healthcare Services

Direct Healthcare Services LtdUnits 8-10 Withey Court Industrial Estate Western Industrial Estate Caerphilly, Wales United Kingdom CF83 1BQMob: +44 (0) 7837 242 731 (Neil) Tel: +44(0)845 459 9831Fax No: +44 (0) 845 459 9832 [email protected]

Sales & Marketing Director Neil Smith comments, “Our next opportunity as a proud British manufacturer is to take our products, skills and experience, all of which require a high level of clinical understanding and attention to detail, to key overseas markets.”

DHS has recently conducted a pilot study within the Irish healthcare market. In keeping with its ‘Deliver the promise’ company slogan, the quality and clinical performance of its value for money products were fully welcomed – a great success

considering the competitive and complex product sector of pressure area care.

The company’s primary aim at Medica is to source and meet “strategic partners” willing to work alongside their vision for the future. They’re looking for distribution partners with

experienced teams to enable market penetration with the Dyna-Form(R), Dyna-Tek(R) and Dyna-Pad(R) brands throughout Europe and globally.

DHS’s combination of innovative technologies, designed in partnership with leading clinical healthcare establishments, meets the needs of targeted patient groups, including the

increasingly elderly population.

Whether you need the provision of a managed pressure care contract, a hospital installation, want

to purchase an item, or are interested in distribution opportunities in countries outside of the UK and Ireland, visit Jon or Neil on the Wales stand, or contact Direct Healthcare Services Ltd (see details below, quoting “Medica Enquiries” to the Customer Service team).

19


DTR Medical Ltd – a leading sterile single-use surgical instrument manufacturer – is developing its business using advanced manufacturing techniques to enable high quality volume production.

Keen to innovate, reduce its carbon footprint, and encourage the use of single-use surgical instruments, DTR Medical is using computer aided design (CAD) and advanced moulding techniques to reproduce products previously sourced from Asia. For instance, the increasingly popular Frazier Suction Handle is now produced locally, enabling DTR Medical to meet the high demand for the product.

Integral to the company is the adherence to international quality standards. By using CAD and automated procedures to produce the Frazier suction handles, the margin of error has been significantly reduced, providing standardized high quality product every time.

Linking the ability to innovate and use the latest lean manufacturing techniques, the company has worked with clinicians to develop their Sterile Single-use Rotating Cervical Biopsy Punch, to remove the risks of cross contamination for patients undergoing cervical cancer biopsies.

With approximately 260,000 cervical biopsies conducted in the UK per annum, DTR Medical’s product has the opportunity to revolutionise this procedure, as it prevents cross-contamination, provides first time sharpness with a precise cut, and fits within healthcare providers’ budgets.

DTR Medical

The nylon-based trigger handle and the metal jaw were developed using the best materials and expertise available, utilising the advice of surgeons to create a truly fit-for-purpose product. The shaft and inner rod - made from stainless steel - actuate the jaw, ensuring no movement or flex occurs, enabling the surgeon to attain a sharp and clean cut.

The product will be launched at a cost effective and affordable price, considerably less than what healthcare providers could pay for a Far East manufactured instrument.

DTR Medical Ltd17 Clarion CourtClarion CloseEnterprise ParkSwansea SA6 8RFUKTel: +44 (0) 1792 797 910Fax: +44 (0) 1792 797 955 E-mail: [email protected]: www.dtrmedical.com

Sterile, Single-use Rotating Cervical Biopsy Punch

Sterile, Single-use Frazier Suction Handles

20

GX Design Engineers is one of the UK’s leading technology and innovation companies. They offer clients, and specifically those in the medical sector, a multidisciplinary and holistic approach to new product design and development.

GX has the ability to turn ideas into viable commercial products that meet the demanding technical requirements of your market.

Comprising a friendly and flexible team of professionals, GX take professional pride in helping clients with multi-faceted challenges.

Clients’ needs are met through engineering excellence and skilful differentiation to deliver products that maintain or grow market share and provide competitive edge.

The in-house team’s skill set includes electronic hardware and software design, industrial and mechanical engineering, with specialists in areas such as optronics and microfluidics.

Combing these capabilities with creativity, experience and absolute problem solving intelligence, GX deliver innovative and commercial solutions that function as required.

Products are aesthetically attractive, ergonomically sound, and can be brought to market quickly. Produced within your target cost, GX can help clients achieve the required return on investment.

GX Group

GX GroupThe MayfieldUSKMonmouthshire UKNP15 1SYTel: +44 (0)1291 673437Web: www.gxgroup.com

Isurgicals - Laparoscopic trainer

Bayer - Clinitek Status - Urine & immuno diagnostics

21


Pulse Medical Technologies Ltd (Pulse) was incorporated to design and develop health care products, initially for the pain relief market. The company has grown and expanded its operations into other areas of healthcare, including wound care, using its core technology of Pulsed Electromagnetic Field Therapy (PEMF) as the base.

PEMF has been used for decades and is FDA approved for various conditions including healing non-union bone fractures, wounds and pain relief. The technology doesn’t have any magnets and has a different mechanism to other treatments e.g. TENS.

Products

PainWave X4000 is the company’s pain relief product and has been used successfully by thousands of people covering a wide range of conditions. Further products are in development.

FP7 Project

The company was awarded a major FP7 EC grant after submitting an idea for a new wound treatment, which incorporates the known healing properties of PEMF and the anti-bacterial properties of silver, within a unique dressing. A consortium was assembled to undertake the project and includes Swansea University and BSN Medical.

Pulse Medical Technologies

Collaboration with the Institute of Life Science and Swansea University

Pulse’s R&D base resides in the Institute of Life Science within Swansea University, Wales, giving it direct access to the extensive research facilities and world class experts in the medical and engineering fields. In addition to the full time post doctorate team, backed by specialist professors working on the FP7 project, the company has appointed a post doctorate to undertake specific research to expand its offering into underserved commercial markets that require innovative solutions.

Medica

The company views Medica as an important event for publicising its products and research projects, and for expanding collaborations with research partners, potential suppliers, distributors and customers. In addition, it provides an insight into trends and innovations and provides a valuable resource for competitor analysis.

Pulse Medical Technologies LtdSwansea UniversitySingleton ParkSwansea SA2 8PPTel: +44 (0)1792 606670Email: [email protected]

22

Offices in Cardiff and Cheltenham

Tel: +44 (0) 2920 786535 Email: [email protected] Web: www.wynne-jones.com

• Patents • Trade Marks • Designs • Domain Names

Exploiting your ideas Affordably!

Protecting your ideas Inventively!

Life Sciences is a priority sector for the Welsh economy.330 Companies

15,000 Employees Focus on Research & Development

Come and visit us. Hall 16, Stand no F30.

Visit business.wales.gov.uk, call the Welsh Government information helpline for business on 03000 6 03000 or email [email protected]

Wales10th Year at Medica

Welsh Government Medica Ad A5.indd 1 26/10/2011 11:30

Medica Special Autumn 2011

Documents

Transcript of Medica Special Autumn 2011